HMH Hospitals Corp DBA CDI
The Center for Discovery and Innovation (CDI) is a research institute focused on biomedical sciences, with a mission to harness innovations in biomedical sciences to restore patient health. It conducts research across various focus areas including behavioral and neurocognitive health, cancer, immunology, infectious diseases, and more. CDI offers advanced research facilities, supports translational research, and fosters collaborations to develop new diagnostics, therapies, and understanding of human diseases. The institute is actively recruiting faculty and provides training programs for researchers and clinicians.
Industries
Nr. of Employees
medium (51-250)
HMH Hospitals Corp DBA CDI
Products
ETMR One registry (international rare tumor data platform)
International registry and research platform for embryonal tumor with multilayer rosettes (ETMR) that centralizes clinical data, enables consensus therapy review, and supports collaborative rare-disease research.
ETMR One registry (international rare tumor data platform)
International registry and research platform for embryonal tumor with multilayer rosettes (ETMR) that centralizes clinical data, enables consensus therapy review, and supports collaborative rare-disease research.
Services
Clinical Immunology Core services
Immunophenotyping, immunological function assays, assay development, sample preparation (stimulation and staining), instrumentation training, and consultation for translational immunology research.
Genomics and Epigenomics core support
Partnerships and core services for genomics, epigenomics, sequencing, and bioinformatics to support variant discovery, methylation profiling, and downstream analysis.
Mass spectrometry imaging and spatial pharmacology services
MSI-based spatial pharmacokinetics and spatial pharmacodynamics analyses, biomarker identification, and method development for translational pharmacology studies.
Preclinical model and animal study support
Design and execution support for animal experiments including genetically engineered models, infection models, and large-animal testing for tissue-engineered grafts.
Diagnostic assay development and evaluation
Development, validation, and evaluation of molecular diagnostic assays (multiplex PCR and related methods) and assessment of rapid molecular diagnostics to inform therapy.
Clinical Immunology Core services
Immunophenotyping, immunological function assays, assay development, sample preparation (stimulation and staining), instrumentation training, and consultation for translational immunology research.
Genomics and Epigenomics core support
Partnerships and core services for genomics, epigenomics, sequencing, and bioinformatics to support variant discovery, methylation profiling, and downstream analysis.
Mass spectrometry imaging and spatial pharmacology services
MSI-based spatial pharmacokinetics and spatial pharmacodynamics analyses, biomarker identification, and method development for translational pharmacology studies.
Preclinical model and animal study support
Design and execution support for animal experiments including genetically engineered models, infection models, and large-animal testing for tissue-engineered grafts.
Diagnostic assay development and evaluation
Development, validation, and evaluation of molecular diagnostic assays (multiplex PCR and related methods) and assessment of rapid molecular diagnostics to inform therapy.
Expertise Areas
- Genomics and epigenomics
- Cancer biology and tumor microenvironment
- Immunology and cellular immunotherapy
- Infectious disease research and antimicrobial resistance
Key Technologies
- Array-based CpG methylation profiling
- Methylation sequencing (Methyl-Seq)
- Allele-specific methylation mapping
- CRISPR/Cas9 gene editing